[07 June 2011]
Products Affected - Description
Fentanyl Transdermal System, Teva25 mcg/hour patch (NDC 00093-6900-45)50 mcg/hour patch (NDC 00093-6901-45)75 mcg/hour patch (NDC 00093-6902-45)100 mcg/hour patch (NDC 00093-6903-45)
Reason for the Shortage
- Tevacould notprovide a reason for the shortage of their products.
- Alza was holdingdistribution of Duragesic patches to Ortho-McNeil-Janssen due to a manufacturing investigation.
Estimated Resupply Dates
- Mallinckrodt has available all fentanyl transdermal patches including 25 mcg/hour (NDC 00409-9025-76), 50 mcg/hour (NDC 00409-9050-76), 75 mcg/hour (NDC 00409-9075-76), and 100 mcg/hour (NDC 00409-9000-76).
- Mylan has available all fentanyl transdermal patches including 12.5 mcg/hour (NDC 00378-9119-98), 25 mcg/hour (NDC 00378-9121-98), 50 mcg/hour (NDC 00378-9122-98), 75 mcg/hour (NDC 00378-9123-98) and 100 mcg/hour (NDC 00378-9124-98) strengths.
- Teva has production of all fentanyl transdermal patches halted indefinitely.
- Watson has available all fentanyl transdermal patches including 25 mcg/hour (NDC 00591-3198-72), 50 mcg/hour (NDC 00591-3212-72), 75 mcg/hour (NDC 00591-3213-72), and 100 mcg/hour (NDC 00591-3214-72) strengths.
- Sandoz has available all fentanyl transdermal patches including 12.5 mcg/hour (NDC 00781-7109-55), 25 mcg/hour (NDC 00781-7111-55), 50 mcg/hour (NDC 00781-7112-55), 75 mcg/hour (NDC 00781-7113-55), and 100 mcg/hour (NDC 00781-7114-55).
- Ortho-McNeil has available Duragesic 12.5 mcg/hour (NDC 50458-0037-05), 25 mcg/hour (NDC 50458-0033-05), 50 mcg/hour (NDC 50458-0034-05), 75 mcg/hour (NDC 50458-0035-05), and 100 mcg/hour (NDC 50458-0036-05) transdermal patches.
- Activis has available all fentanyl transdermal patches including 25 mcg/hour (NDC 67767-0120-18), 50 mcg/hour (NDC 67767-0121-18), 75 mcg/hour (NDC 67767-0122-18), and 100 mcg/hour (NDC 67767-0123-18) strengths.
Related Shortages
Updated
June 7, 2011; May 19, 2011; May 13, 2011; April 26, 2011; April 21, 2011; April 15, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins
Get the latest updates on ASHP's advocacy activity on drug shortages.